ARTICLE | Company News
Mitsubishi Tanabe Pharma sales and marketing update
April 8, 2013 7:00 AM UTC
Mitsubishi's Mitsubishi Pharma Deutschland GmbH subsidiary launched BindRen colestilan in Germany and Austria to treat hyperphosphatemia in adult patients with stage 5 chronic kidney disease (CKD) re...